Geneos Wealth Management Inc. - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 155 filers reported holding AMNEAL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
Geneos Wealth Management Inc. ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$02000.0%0.00%
Q1 2022$0
-100.0%
200
-0.5%
0.00%
Q3 2021$1,0000.0%2010.0%0.00%
Q2 2021$1,000
-50.0%
201
-61.5%
0.00%
Q1 2021$2,000
+100.0%
522
+161.0%
0.00%
Q4 2020$1,0000.0%2000.0%0.00%
Q2 2019$1,000
-50.0%
2000.0%0.00%
Q1 2019$2,0000.0%2000.0%0.00%
Q4 2018$2,000
-50.0%
2000.0%0.00%
Q3 2018$4,000
+33.3%
2000.0%0.00%
Q2 2018$3,0002000.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$83,503,0007.34%
Eversept Partners, LP 2,656,208$10,306,0872.29%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$62,908,0001.13%
Prosight Management, LP 512,659$1,989,0000.95%
THB ASSET MANAGEMENT 833,104$3,232,0000.90%
GLOBEFLEX CAPITAL L P 251,696$977,0000.26%
XTX MARKETS LLC 10,243$40,0000.19%
HUSSMAN STRATEGIC ADVISORS, INC. 102,000$396,0000.10%
PA Capital LLC 33,874$132,0000.09%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 60,900$236,0000.07%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders